Cargando…
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369851/ https://www.ncbi.nlm.nih.gov/pubmed/34413902 http://dx.doi.org/10.1177/17562864211038111 |
| _version_ | 1783739369229647872 |
|---|---|
| author | Capuano, Rocco Donnarumma, Giovanna Bisecco, Alvino Grimaldi, Elena Conte, Miriana d’Ambrosio, Alessandro Matrone, Federica Risi, Mario Borgo, Riccardo Maria Altieri, Manuela Giuliano, Federica Coppola, Nicola Galdiero, Massimiliano Tedeschi, Gioacchino Gallo, Antonio |
| author_facet | Capuano, Rocco Donnarumma, Giovanna Bisecco, Alvino Grimaldi, Elena Conte, Miriana d’Ambrosio, Alessandro Matrone, Federica Risi, Mario Borgo, Riccardo Maria Altieri, Manuela Giuliano, Federica Coppola, Nicola Galdiero, Massimiliano Tedeschi, Gioacchino Gallo, Antonio |
| author_sort | Capuano, Rocco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8369851 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83698512021-08-18 Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab Capuano, Rocco Donnarumma, Giovanna Bisecco, Alvino Grimaldi, Elena Conte, Miriana d’Ambrosio, Alessandro Matrone, Federica Risi, Mario Borgo, Riccardo Maria Altieri, Manuela Giuliano, Federica Coppola, Nicola Galdiero, Massimiliano Tedeschi, Gioacchino Gallo, Antonio Ther Adv Neurol Disord Neurology in the Time of COVID-19 SAGE Publications 2021-08-13 /pmc/articles/PMC8369851/ /pubmed/34413902 http://dx.doi.org/10.1177/17562864211038111 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Neurology in the Time of COVID-19 Capuano, Rocco Donnarumma, Giovanna Bisecco, Alvino Grimaldi, Elena Conte, Miriana d’Ambrosio, Alessandro Matrone, Federica Risi, Mario Borgo, Riccardo Maria Altieri, Manuela Giuliano, Federica Coppola, Nicola Galdiero, Massimiliano Tedeschi, Gioacchino Gallo, Antonio Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab |
| title | Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab |
| title_full | Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab |
| title_fullStr | Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab |
| title_full_unstemmed | Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab |
| title_short | Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab |
| title_sort | humoral response to sars-cov-2 mrna vaccine in patients with multiple sclerosis treated with natalizumab |
| topic | Neurology in the Time of COVID-19 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369851/ https://www.ncbi.nlm.nih.gov/pubmed/34413902 http://dx.doi.org/10.1177/17562864211038111 |
| work_keys_str_mv | AT capuanorocco humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT donnarummagiovanna humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT biseccoalvino humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT grimaldielena humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT contemiriana humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT dambrosioalessandro humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT matronefederica humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT risimario humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT borgoriccardomaria humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT altierimanuela humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT giulianofederica humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT coppolanicola humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT galdieromassimiliano humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT tedeschigioacchino humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab AT galloantonio humoralresponsetosarscov2mrnavaccineinpatientswithmultiplesclerosistreatedwithnatalizumab |